Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies823
Dune Sciences
Dune Sciences provides solutions for characterizing and manipulating materials on a molecular scale.
Sector
Subsector
Keywords
Location
total rounds
total raised
SBA Materials
SBA Materials develops functional porous materials for various technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
TMM Disruptive Advanced Materials
TMM creates sustainable and low-cost Nanomaterials for commercial markets from waste products.
Sector
Subsector
Location
Advanced Softmaterials Inc.
Advanced Softmaterials Inc. has developed a highly-advanced and environmentally-sound material with movable crosslinks.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 14.02.2023. Their latest investor Cox Enterprises. Their latest round Series C
ArrowMark Partners
ArrowMark Partners is an employee-owned asset management firm founded in 2007.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Viking Global Investors
Viking Global Investors manages over $40 billion of capital across long/short, long-only, public/private hybrid and private-only strategies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors10
Number of lead investors
Number of investors
Cox Enterprises
Cox Enterprises is a leading communications, media, and automotive services company.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
ArrowMark Partners
ArrowMark Partners is an employee-owned asset management firm founded in 2007.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
KdT Ventures
KdT Ventures is a venture capital firm that invests in startups in the data, engineering, and biology sector.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Cain McClary
Dr. Andrew Cain McClary is the Founder and serves as Managing Partner at KdT Ventures. He serves as Board Member at Azitra and Checkerspot.. He serves as Advisor at 8VC. During his undergraduate studies, he studied proteins involved in the development of appendages, both in the labs of Dr. Kristi Wharton at Brown University and Dr. Fred Kaplan at the University of Pennsylvania. Following Brown, he went on to receive his medical degree from Tulane University School of Medicine in 2012. During medical school, he also spent a year at the National Institutes of Health (NIH) as part of the prestigious Howard Hughes Medical Institute "Cloister" Fellowship, where he studied the role of non-coding RNA in cancer at the National Cancer Institute (NCI) in the lab of Dr. Curtis Harris. Immediately following medical school, he underwent residency training in anatomic pathology at Stanford University, where during his final year, he was named Chief Resident. While in residency, he discovered a genetic mutation in a rare jaw tumor, ameloblastoma. This discovery subsequently led to a successful phase IV clinical trial of BRAF inhibitors in ameloblastoma, a condition where previously surgery was the only option. Due to this success, he was appointed as Assistant Professor in the Department of Pathology at Stanford University, becoming the youngest person on faculty in pathology at the time. He has won several notable awards, spoken at universities and national conferences, and published more than 10 peer-reviewed articles. He serves as Board Member at Debut. He is an Angel Investor. He received his BSc in Biochemistry and Molecular Biology from Brown University in 2007
current job
organization founded
People
Founders2
Charles Dimmler
CHARLES DIMMLER is the co-founder and CEO of Checkerspot. His career has focused on building and leading teams at emerging growth companies in the life sciences and biotechnology sector. He has deep expertise in general management and leading strategic transactions, with over $1 billion of completed transactions ranging from public and private financings to joint ventures, licensing and M&A. From 2008 to 2016, he served as Senior Vice President of Corporate Development at Solazyme, Inc. where he led financings and a range of other strategic transactions, including two venture capital rounds, the initial public offering, two public convertible debt issuances, and project financing for the construction of a commercial scale manufacturing facility in Brazil. In addition to his corporate development responsibilities, he served as Acting General Manager of Solazyme’s personal care business in 2009. Prior to Solazyme, Charles was the General Manager of Geron BioMed, Ltd., a wholly-owned subsidiary of Geron Corporation, where he led a team focused on developing R&D and preclinical cell therapy candidates. Charles began his career as an investment banker at Peter J. Solomon Company. Since 2008, Charles has remained active in his community as an Operations Leader with the Bay Area Mountain Rescue Unit, the mountain search and rescue team of the San Mateo County Sheriff. Charles earned his MBA from the Stanford Graduate School of Business and his BA from Columbia University.
current job
organization founded
Charles Dimmler
Scott Franklin
SCOTT FRANKLIN is the scientific co-founder and Chief Scientific Officer of Checkerspot where he oversees the development of their advanced materials innovation technology platform. Scott has a doctorate in Biology from the University of Texas at Austin and 30 years of experience in plant molecular biology, microbiology, algal molecular genetics and recombinant protein expression. He has successfully developed novel organisms as platforms for the production of therapeutic proteins, fuels, foods and oleochemicals. This is Scott’s second start up venture, the first being Rincon Pharmaceuticals in 2004. Scott enjoys managing highly innovative teams while interfacing with corporate partners. He has successfully built technical, intellectual property and regulatory teams around industrial microbe platforms, while concurrently managing relationships and delivering on milestones with partners such as Chevron (San Ramon, CA), Unilever (Trumbull, CT), DOW Chemical (Midland, MI), Mitsui Chemical (Rye Brook, NY), AkzoNobel (Amsterdam, NL), Bunge (White Plains, NY) and Biogen Idec (Cambridge, MA), to name a few. As Vice President of Discovery and Molecular Biology at Solazyme, Scott was responsible for the successful development of the company’s tailored oils platform, engineering and improving algal strains that resulted in the delivery of thousands of metric tons of triglyceride oils for myriad partners including the United States Navy, Unilever, Bunge, Chevron, DOW, Mitsui and AkzoNobel. Scott is co-author on 52 issued patents.
current job
organization founded
Scott Franklin
Employee Profiles3
Activity
Recent News5
The graph reveals the ratio (%) of positive news articles in a chosen time range